We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

25 hedge funds and large institutions have $23.9M invested in Sinovac Biotech, Ltd in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more funds holding

Funds holding: 23 → 25 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

35% less capital invested

Capital invested by funds: $36.7M → $23.9M (-$12.9M)

Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$202K
2
UBS Group
UBS Group
Switzerland
+$12.9K
3
TRCT
Tower Research Capital (TRC)
New York
+$3K
4
FGAM
Financial Gravity Asset Management
Texas
+$33

Top Sellers

Rank Fund Capital Flow
1
NA
Navellier & Associates
Nevada
-$15.4K
2
FIM
Freedom Investment Management
Connecticut
-$188
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$17.2M – – –
NAH
2
Neumann Advisory (HK)
Hong Kong
$2.04M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$1.54M – – –
State Street
4
State Street
Massachusetts
$1.04M – – –
YMRC
5
Yorktown Management & Research Company
Virginia
$485K – – –
California Public Employees Retirement System
6
California Public Employees Retirement System
California
$445K – – –
Skandinaviska Enskilda Banken (SEB)
7
Skandinaviska Enskilda Banken (SEB)
Sweden
$259K – – –
CIBC Private Wealth Group
8
CIBC Private Wealth Group
Georgia
$202K +$202K +24,600 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$179K – – –
NA
10
Navellier & Associates
Nevada
$161K -$15.4K -2,368 -9%
FIM
11
Freedom Investment Management
Connecticut
$134K -$188 -29 -0.1%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$106K – – –
Northern Trust
13
Northern Trust
Illinois
$55K – – –
UBS Group
14
UBS Group
Switzerland
$55K +$12.9K +2,000 +31%
Morgan Stanley
15
Morgan Stanley
New York
$9K – – –
FGAM
16
Financial Gravity Asset Management
Texas
$6K +$33 +1 +0.5%
Group One Trading
17
Group One Trading
Illinois
$3K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$3K +$3K +424 New

SVA Hedge Fund Activity: Q4 2019 in Review

25 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q4 2019, worth a combined $23.9M — down 35% from $36.7M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SVA positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was CIBC Private Wealth Group, opening a new position worth an estimated $202K. The largest seller was Navellier & Associates, cutting an estimated $15.4K.

  • 25 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q4 2019, up from 23 in Q3 2019.
  • Funds reported $23.9M of Sinovac Biotech, Ltd stock for Q4 2019, down 35% quarter-over-quarter.
  • 2 funds opened new Sinovac Biotech, Ltd positions in Q4 2019 and 0 closed out, a net change of +2 holders.
  • The largest Sinovac Biotech, Ltd buyer in Q4 2019 was CIBC Private Wealth Group, an estimated $202K added.
  • The largest Sinovac Biotech, Ltd seller in Q4 2019 was Navellier & Associates, an estimated $15.4K sold.

Based on aggregated 13F filings for Q4 2019.